It has recently been shown that mdm2 overexpression with stabilization of p53 represents a characteristic of retroperitoneal well-differentiated-dedifferentiated, here renamed evolved (WD-E), liposarcomas at the immunocytochemical, molecular, and cytogenetic level. This make-up appears to be confine
Complexity of 12q13–22 amplicon in liposarcoma: Microsatellite repeat analysis
✍ Scribed by Maija Wolf; Lauri A. Aaltonen; Jadwiga Szymanska; Maija Tarkkanen; Carl Blomqvist; Jeanne-Marie Berner; Ola Myklebost; Sakari Knuutila
- Book ID
- 101259967
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 116 KB
- Volume
- 18
- Category
- Article
- ISSN
- 1045-2257
No coin nor oath required. For personal study only.
✦ Synopsis
The 12q13-22 amplicon from four liposacroma specimens evaluated by comparative genomic hybridization was studied analyzing 55 microsatellite markers by PCR. All four specimens were informative in at least 34 loci; an amplification or allelic imbalance was identified with four to 17 markers. The amplicons were discontinuous; there were non-amplified marker loci between the amplified marker loci. These findings indicate the presence of separate amplicons in the 12q13-22 region. Evidence of the concomitant gain of one allele and loss of the other allele was found with several markers in one tumor and with one marker in two tumor specimens. Southern blotting showed amplification of CDK4 and MDM2 in all four specimens.
📜 SIMILAR VOLUMES
A case of partial trisomy 9 is described in a mentally retarded and dysmorphic child, confirming that this chromosome unbalance results in a characteristic clinical entity. This trisomy arose through aberrant segregation of translocation chromosome during meiosis in the patient's mother, who is a ba
## Abstract Well‐differentiated liposarcomas (WDLPS) classically contain high‐level amplification of 12q14‐15 sequences, including the __MDM2__ and __CDK4__ genes, while lipomas are characterized by simple structural chromosome aberrations often involving __HMGA2__ at 12q15. Previous studies have s
## Abstract The chromosomal region 11q13 is amplified in 15–20% of breast cancers; an event not only associated with estrogen receptor (ER) expression but also implicated in resistance to endocrine therapy. Coamplifications of the 11q13 and 8p12 regions are common, suggesting synergy between the am